Trial Details
COMPLETEDBasic Information
| Clinical ID | c3561 |
|---|---|
| Identifier | NCT01855711 |
| Trial Title | Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Colon |
| Interventions | DRUG: GR68755 (Alosetron hydrochloride) 1 mg tablet |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2003-09-18 |
|---|---|
| Primary Completion Date | 2005-05-10 |
| Completion Date | 2005-05-10 |